Racial Differences in Naturalistic Psychedelic Use — Motivations for Use, Communication with Health Care Providers, and Outcomes
Bibliographic Data
| ID | 13913136 |
|---|---|
| Authors | Nicolas G Glynos (0000-0002-6952-131X, University of Michigan Medical School, corresponding author), Mallet R Reid (0000-0001-5529-2483, Michigan State University), Jacob S Aday (0000-0003-0578-8530, University of Michigan Medical School), D J Kruger (0000-0002-2757-7016, University of Michigan), Kevin F Boehnke (0000-0003-3696-3979, University of Michigan Medical School), Stephanie Lake (0000-0002-4095-8016, University of California System), Philippe Lucas (0000-0003-1948-3842, University of Michigan) |
| Year | 2025 |
| Pages | 1-12 |
| Publication date | 2025-04-22 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Psychoactive Drugs (JOURNAL) |
| Journal identifiers | ISSN: 0279-1072 • E-ISSN: 2159-9777 |
| Publisher | Taylor & Francis (PUBLISHER • GB) |
| DOI | 10.1080/02791072.2025.2491381 |
| PMID | 40260901 |
| OpenAlex | W4409653629 |
| Language | EN |
| References cited | 31 |
People of Color have been under-included in psychedelic-assisted therapy (PAT) research. Researchers have argued that systemic issues resulting in harms to communities of color like the War on Drugs and recurrent exposure to discrimination in healthcare settings may reduce their willingness to engage in PAT research. However, there are no empirical data regarding People of Color's trust or willingness in using psychedelics with support of trained healthcare providers. Therefore, we analyzed data from a large-scale survey of people using psychedelics to explore interactions between People of Color and healthcare providers in North America. The sample included 3,547 White people, 448 People of Color, and 377 Multiracial people. A lower proportion of People of Color consumed psychedelics with the support of a trained provider but an equal proportion had disclosed psychedelic use to primary care providers. Further, People of Color were equally motivated to use psychedelics with a trained healthcare provider, used psychedelics to treat similar issues, and similarly reported psychedelics as effective with other groups. Our findings suggest that lack of trust may not fully explain the underrepresentation of People of Color in PAT research, and future studies should investigate other barriers to People of Color's inclusion in PAT research
Ethnic group · Health care · Naturalistic observation · Psychiatry · Racial differences · Substance use · Chemical synthesis and alkaloids · Clinical Psychology · Medicine · Nicotinic Acetylcholine Receptors Study · Psychedelics and Drug Studies · Psychology · Social Psychology
Inclusion of people of color in psychedelic-assisted psychotherapy
Long-term effects of psychedelic drugs
Emotional breakthrough and psychedelics
Racial and ethnic differences in depression
A Brief Measure for Assessing Generalized Anxiety Disorder
The PHQ-8 as a measure of current depression in the general population
People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences
Whitewashing psychedelics
Psychedelic substitution
The Need for Psychedelic-Assisted Therapy in the Black Community and the Burdens of Its Provision
Systemic biases promoting the under-inclusion of marginalized groups in randomized controlled trials for co-occurring alcohol use and posttraumatic stress disorder
Cognitive behavioral therapy
A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy
Ensuring the psychedelic renaissance and radical healing reach the Black community
Prevalence, Severity and Burden of Post-Traumatic Stress Disorder in Black Men and Women Across the Adult Life span
Enactments of racial microaggression in everyday therapeutic encounters
| Highly cited | No |
|---|